FinanceAsianet Newsable
OTLK Stock Jumps Overnight After FDA Approval Of Wet AMD Drug — Analysts See Nearly 300% Upside
in5points
Outlook Therapeutics received FDA approval for its wet AMD drug.
OTLK stock jumped overnight on the news.
Analysts see nearly 300% upside for the stock.
Outlook expects a U.S. launch before year-end.
The company anticipates 12 years of market exclusivity.
Story angle
Center
L
CL
C
CR
R
Near the middle: closer to straight reporting, less party-line spin.
About how the story is framed, not whether the facts are true.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically